Published January 23, 2008
| Supplemental Material + Accepted Version
Journal Article
Open
The Catalytic Asymmetric Total Synthesis of Elatol
Abstract
Described in this report is the first total synthesis of elatol, a halogenated sesquiterpene in the chamigrene natural product family. The key disconnections in our synthetic approach include an enantioselective decarboxylative allylation to form the all-carbon quaternary stereocenter and a ring-closing olefin metathesis to concomitantly form the spirocyclic core as well as the fully substituted chlorinated olefin. This strategy represents a general platform for accessing the chamigrene natural product family, as demonstrated by the synthesis of (+)-laurencenone B as an intermediate in our route.
Additional Information
© 2008 American Chemical Society. Received 13 November 2007. Published online 29 December 2007. Published in print 1 January 2008. We thank the NIH-NIGMS (R01 GM080269-01, R01 GM31332-05, postdoctoral fellowships to D.E.W. and I.C.S.), Abbott, Amgen, Bristol-Myers Squibb, Merck, and Caltech for generous funding; Materia, Inc. for their kind donation of catalyst 22 used in these studies; Professors Mercedes Cueto and Karen L. Erickson for their kind donation of natural samples of elatol (1); Brinton Seashore-Ludlow for experimental assistance; and Professor Peter B. Dervan and David M. Chenoweth for use of their HPLC.Attached Files
Accepted Version - nihms62867.pdf
Supplemental Material - ja710294k-file002.pdf
Files
nihms62867.pdf
Files
(2.2 MB)
Name | Size | Download all |
---|---|---|
md5:c56c3504660629f1cac73f81db5949d2
|
636.7 kB | Preview Download |
md5:0a99eadca1be25f009e24743c8f4d4fe
|
1.6 MB | Preview Download |
Additional details
- PMCID
- PMC2533138
- Eprint ID
- 74453
- Resolver ID
- CaltechAUTHORS:20170222-082042531
- NIH
- R01GM080269-01
- NIH
- R01GM31332-05
- Abbott
- Amgen
- Bristol-Myers Squibb
- Merck
- Caltech
- Created
-
2017-02-22Created from EPrint's datestamp field
- Updated
-
2021-11-11Created from EPrint's last_modified field